(168 days)
The SSU Flexible Video-Uretero-Renoscope System is indicated for endoscopic examination in the urinary tract and can be used to examine the interior of the kidney, and using additional accessories, to perform various diagnostic and therapeutic procedures.
E-Box: the product serves as an adaptor for operating the flexible single-use videoscope on the compatible CCU.
The videoscopes in the modified Flexible Video-Uretero-Renoscope SSU System are sterile single-use, flexible video-endoscopes. The distal tip houses the CMOS (Complementary Metal Oxide Semiconductor) imaging sensor and the LED light source. The raw data captured at the distal tip CMOS imaging censor is transferred to the E-Box adaptor, where it is converted to a standard NTSC (National Television System Committee) video signal by the PCB (Printed Circuit Board), which is then driven into one of the CCUs (C-MAC, C-HUB II, or X-LINK + IMAGE 1S Connect) for further processing and video formatting for output to a display monitor. The videoscopes and E-Box are powered by the CCUs through the connecting cords.
Here's a summary of the acceptance criteria and study information based on the provided text, focusing on the performance of the SSU Flexible Video-Uretero-Renoscope System:
1. A table of acceptance criteria and the reported device performance
The document does not explicitly state acceptance criteria in numerical terms for the performance characteristics. Instead, it compares the subject device's performance characteristics to those of a predicate device (KARL STORZ Flexible Video-Uretero-Renoscope System K141250) to demonstrate substantial equivalence. The "Acceptance Criteria" column below will reflect the predicate device's corresponding specifications where applicable, or indicate "Met design specifications" if specific targets for the subject device are not detailed but performance testing was done.
| Characteristic | Acceptance Criteria (Predicate Device K141250) | Reported Device Performance (SSU Flexible Video-Uretero-Renoscope SSU System) |
|---|---|---|
| Maximal Outer diameter Insertion Portion | Same as subject device | 3.2 mm |
| Outer diameter Insertion Tube | Same as subject device | 2.9 mm |
| Outer diameter Distal End | Same as subject device | 3.2 mm |
| Insertion portion length | 675 mm | 700 mm |
| Working channel | Present | Present |
| Inner diameter Working Channel | Same as subject device | 1.2 mm |
| Tip deflection up/down | Same as subject device | 270°/270° |
| Field of view | 90° | 110° |
| Direction of View | Same as subject device | 0° |
| Depth of Field | 4 - 60 mm | 5 - 50 mm |
| On-axis Resolution (at 5/4 mm) | 11.0 Lp/mm at 4 mm | 12.5 Lp/mm at 5 mm |
| On-axis Resolution (at 15/12 mm) | 4.0 Lp/mm at 12 mm | 4.5 Lp/mm at 15 mm |
| On-axis Resolution (at 50/60 mm) | 1.0 Lp/mm at 60 mm | 1.25 Lp/mm at 50 mm |
| Chip type | Same as subject device | CMOS |
| Chip location | Same as subject device | Distal |
| Illumination source | Same as subject device | LED |
| Compatible CCU | Image 1S | C-MAC, C-HUB II, Image 1S |
| How device is provided | Unsterile, reusable | Sterile single-use |
| EO Sterilization cycle | N/A | EO, Overpressure 2.7 bar absolute, 8.5 % ETO in 91.5 % C02 |
| Sterilizing Agent | N/A | Ethylene Oxide (EO) |
| Electrical Safety and EMC | IEC 60601-1, IEC 60601-1-2, IEC 60601-2-18 | Met requirements of these standards |
| IEC 62471 | Met requirements of this standard | Met requirements of this standard |
| ISO 10993 | Met requirements of this standard | Met requirements of this standard |
| ISO 8600 | Met requirements of this standard | Met requirements of this standard |
| Performance Testing (General) | Not explicitly detailed | Performed (Color Contrast Enhancement, Image intensity uniformity, Depth of field & Spatial Resolution, Distortion, Signal-to-Noise Ratio (SNR) & Sensitivity) - Met design specifications. |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
The document states, "Clinical testing was not required to demonstrate the substantial equivalence to the predicate devices. Non-clinical bench testing was sufficient to establish the substantial equivalence of the modifications." This indicates that no clinical test set (i.e., human patient data) was used.
The performance was evaluated through non-clinical bench testing. The sample size for these bench tests is not explicitly stated in the provided text, nor is the provenance of the data from these bench tests (e.g., if specific components were sourced from different countries or if testing was done in a specific lab location). The submitter, KARL STORZ SE & Co. KG, is located in Tuttlingen, Germany.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
Since no clinical testing was performed, no experts were used to establish ground truth for a clinical test set. The performance was evaluated against design specifications and recognized consensus standards by the technical personnel conducting the bench testing.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
As no clinical test set was used, no adjudication method was applicable or performed.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
No MRMC comparative effectiveness study was done. The device itself is an endoscope system, not an AI-assisted diagnostic tool.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done
Not applicable. This device is an endoscope system that requires human operation and interpretation. It is not an algorithm performing a standalone task.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
For the non-clinical bench testing, the "ground truth" implicitly used would be engineering and physical measurements taken against established specifications and recognized consensus standards. For example, "on-axis resolution" would be measured using standardized targets and optical equipment, with the expected values derived from known optical principles and predicate device data.
8. The sample size for the training set
Not applicable. This device is a hardware medical device (an endoscope system), not a machine learning or AI algorithm that requires a "training set" in the conventional sense. Its design and performance are based on engineering principles and verified through bench testing.
9. How the ground truth for the training set was established
Not applicable. As there is no training set for an AI algorithm.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logos of the Department of Health & Human Services and the Food and Drug Administration (FDA). The Department of Health & Human Services logo is on the left, and the FDA logo is on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
January 20, 2022
KARL STORZ Endoscopy-America, Inc. Mario Trujillo Regulatory Affairs Specialist 2151 E. Grand Avenue El Segundo, CA 90245
Re: K212458
Trade/Device Name: SSU Flexible Video-Uretero-Renoscope System Regulation Number: 21 CFR§ 876.1500 Regulation Name: Endoscope and Accessories Regulatory Class: II Product Code: FGB Dated: December 20, 2021 Received: December 21, 2021
Dear Mario Trujillo:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
{1}------------------------------------------------
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatoryinformation/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Mark J. Antonino, M.S. Assistant Director DHT3B: Division of Reproductive. Gynecology and Urology Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K212458
Device Name
SSU Flexible Video-Uretero-Renoscope System
Indications for Use (Describe)
The SSU Felxible Video-Uretero-Renoscope System is indicated for endoscopic examination in the urinary tract and can be used to examine the interior of the kidney, and using additional accessories, to perform various diagnostic and therapeutic procedures.
E-Box: the product serves as an adaptor for operating the flexible single-use videoscope on the compatible CCU.
Type of Use (Select one or both, as applicable)
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the logo for Karl Storz Endoskope. The logo is in blue and features the word "STORZ" in large, bold letters. Below the word "STORZ" is the phrase "KARL STORZ - ENDOSKOPE" in smaller letters.
510(k) Summary
This 510(k) Summary is being submitted in accordance with the requirements of the Safe Medical Devices Act (SMDA) of 1990 and 21 CFR 807.92 and the FDA guidance document titled "The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]" issued on July 28, 2014. All data included in this document is accurate and complete to the best of KARL STORZ SE & Co. KG knowledge.
| Submitter: | KARL STORZ SE & Co. KGDr.-Karl-Storz-Straße 3478532 Tuttlingen, Germany |
|---|---|
| Contact: | Mario TrujilloAssociate Regulatory Affairs SpecialistTel.: (424) 218-8481Email: Mario.Trujillo@karlstorz.com |
| Date of Preparation: | September 7, 2021 |
| Type of 510(k) Submission: | Traditional |
| Device Identification: | Trade Name: SSU Flexible Video-Uretero-Renoscope SystemClassification Name: Endoscope and Accessories(21 CFR Part 876.1500); |
| Regulatory Class: | II |
| Product Code: | FGB |
| Guidance Document: | Not Applicable |
| Predicate Device: | KARL STORZ Flexible Video-Uretero-Renoscope System (K141250). |
| Device Description: | The videoscopes in the modified Flexible Video-Uretero-RenoscopeSSU System are sterile single-use, flexible video-endoscopes. Thedistal tip houses the CMOS (Complementary Metal OxideSemiconductor) imaging sensor and the LED light source. The rawdata captured at the distal tip CMOS imaging censor is transferred tothe E-Box adaptor, where it is converted to a standard NTSC(National Television System Committee) video signal by the PCB(Printed Circuit Board), which is then driven into one of the CCUs (C-MAC, C-HUB II, or X-LINK + IMAGE 1S Connect) for furtherprocessing and video formatting for output to a display monitor. Thevideoscopes and E-Box are powered by the CCUs through theconnecting cords. |
| Intended Use: | The SSU Flexible Video-Uretero-Renoscope is intended forvisualization purposes during urological procedures. |
{4}------------------------------------------------
Image /page/4/Picture/0 description: The image shows the logo for Karl Storz Endoskope. The word "STORZ" is in large, bold, blue letters on the top line. The words "KARL STORZ - ENDOSKOPE" are in smaller, blue letters on the bottom line.
| Indications For Use: | The SSU Flexible Video-Uretero-Renoscope is indicated forendoscopic examination in the urinary tract and can be used toexamine the interior of the kidney, and using additional accessories,to perform various diagnostic and therapeutic procedures.E-Box: the product serves as an adaptor for operating the flexiblesingle-use videoscope on the compatible CCU. | ||
|---|---|---|---|
| TechnologicalCharacteristics: | Comparison Table: Subject vs. Predicate Devices | ||
| Subject Device | Predicate Device, K141250 | ||
| Flexible Video-Uretero-RenoscopeSSU System | Flexible Video-Uretero-Renoscope System | ||
| Maximal Outer diameterInsertion Portion | 3.2 mm | Same as subject device | |
| Outer diameter InsertionTube | 2.9 mm | Same as subject device | |
| Outer diameter Distal End | 3.2 mm | Same as subject device | |
| Insertion portion length | 700 mm | 675 mm | |
| Working channel | Present | Same as subject device | |
| Inner diameter WorkingChannel | 1.2 mm | Same as subject device | |
| Tip deflection up/down | 270°/270° | Same as subject device | |
| Field of view | 110° | 90° | |
| Direction of View | 0° | Same as subject device | |
| Depth of Field | 5 - 50 mm | 4 - 60mm | |
| On-axis Resolution | 12.5 Lp/mm at 5 mm4.5 Lp/mm at 15 mm1.25 Lp/mm at 50 mm | 11.0 Lp/mm at 4 mm4.0 Lp/mm at 12 mm1.0 Lp/mm at 60 mm | |
| Chip type | CMOS | Same as subject device | |
| Chip location | Distal | Same as subject device | |
| Illumination source | LED | Same as subject device | |
| Compatible CCU | C-MACC-HUB IIImage 1S | Image 1S | |
| How device is provided | Sterile single-use | Unsterile, reusable | |
| EO Sterilization cycle | EO, Overpressure 2.7bar absolute, 8.5 % ETOin 91.5 % C02 | N/A | |
| Sterilizing Agent | Ethylene Oxide (EO) | N/A | |
| Non-ClinicalPerformance Data: | There are no performance standards or special controls developed underSection 514 of the FD&C Act for endoscopes. However, the subject devicefollows the FDA recognized consensus standards and is tested according tothe following standards and FDA Guidance:Electrical Safety and EMC IEC 60601-1 IEC 60601-1-2 IEC 60601-2-18 | ||
| ο | IEC 62471 | ||
| ο | ISO 10993 | ||
| ο | ISO 8600 | ||
| • | Performance Testing | ||
| ο | Color Contrast Enhancement | ||
| ο | Image intensity uniformity | ||
| ο | Depth of field & Spatial Resolution | ||
| ο | Distortion | ||
| ο | Signal-to-Noise Ratio (SNR) & Sensitivity | ||
| Additional bench testing was performed to ensure the device met its designspecifications. The bench testing performed verified and validated that theSSU Flexible Video-Uretero-Renoscope has met all its designspecification and is substantially equivalent to its predicate devices. | |||
| Clinical PerformanceData: | Clinical testing was not required to demonstrate the substantialequivalence to the predicate devices. Non-clinical bench testing wassufficient to establish the substantial equivalence of themodifications. | ||
| Conclusion: | The conclusions drawn from the nonclinical tests demonstrate thatthe subject devices, the SSU Flexible Video-Uretero-Renoscopeperforms as well as or better than the predicate devices that arecurrently marketed for the same intended use. |
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image shows the logo for Karl Storz Endoskope. The logo is in blue and features the word "STORZ" in large, bold letters. Below the word "STORZ" is the phrase "KARL STORZ - ENDOSKOPE" in a smaller, less bold font.
510(k) Summary
§ 876.1500 Endoscope and accessories.
(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.